AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334,840 | +8.3% | 6,620 | 0.0% | 0.04% | +9.4% |
| Q2 2023 | $309,088 | +13.5% | 6,620 | -7.0% | 0.03% | +10.3% |
| Q1 2023 | $272,411 | -34.3% | 7,120 | -5.9% | 0.03% | -38.3% |
| Q4 2022 | $414,836 | +26.5% | 7,570 | -21.3% | 0.05% | +14.6% |
| Q3 2022 | $328,000 | +185.2% | 9,620 | -20.6% | 0.04% | +192.9% |
| Q2 2022 | $115,000 | -20.1% | 12,120 | +19.8% | 0.01% | -17.6% |
| Q1 2022 | $144,000 | -29.1% | 10,120 | +5.2% | 0.02% | -34.6% |
| Q4 2021 | $203,000 | – | 9,620 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 1,621,829 | $75,723,196 | 32.88% |
| COMMODORE CAPITAL LP | 1,675,000 | $78,205,750 | 8.79% |
| Ghost Tree Capital, LLC | 360,000 | $16,808,400 | 5.55% |
| Boxer Capital, LLC | 1,676,733 | $78,287 | 3.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 241,357 | $11,268,958 | 3.49% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $27,745,579 | 3.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 236,500 | $11,039,820 | 3.42% |
| Logos Global Management LP | 520,000 | $24,278,800 | 3.30% |
| Redmile Group, LLC | 1,811,672 | $84,586,966 | 3.25% |
| Yiheng Capital Management, L.P. | 1,201,591 | $56,102,284 | 3.03% |